ENDONOVO THERAPEUTICS, INC. (ENDV) › Net IncomeENDONOVO THERAPEUTICS, INC. (ENDV) — Net IncomeAnnual figures by fiscal year, from SEC filings.2010: -$69.4K2011: -$94.1K2012: -$1.91M2013: -$2.89M2014: -$959.5K2015: -$6.77M2016: -$5.32M2017: -$10.81M2018: -$6.44M2019: -$17.31M2020: -$395.6K2021: -$3.10M2022: -$18.47M-$18.47M2010Net Income (USD)2022Fiscal YearNet IncomeChange YoY2022-$18.47M-495.0%2021-$3.10M-684.9%2020-$395.6K+97.7%2019-$17.31M-169.0%2018-$6.44M+40.5%2017-$10.81M-103.4%2016-$5.32M+21.4%2015-$6.77M-605.1%2014-$959.5K+66.8%2013-$2.89M-51.1%2012-$1.91M-1934.9%2011-$94.1K-35.6%2010-$69.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share